NCT04899791

Brief Summary

Hydroxytyrosol is a phenolic compound drawn from the olive tree and its leaves as a by-product obtained from the manufacturing of olive oil and has antioxidant and antidiabetic effects. The use of HT extract in food products is a good strategy to improve their nutritional quality. However, this extract has a strong odour and flavour, so it is important to be encapsulated for the odour and flavour to be covered up. The purpose of the study is to investigate the effects of regular consumption of bread enriched with HT on biochemical parameters (blood glucose and cholesterol levels).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started May 2021

Shorter than P25 for not_applicable type-2-diabetes-mellitus

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

May 24, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2021

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 14, 2022

Completed
Last Updated

March 2, 2022

Status Verified

February 1, 2022

Enrollment Period

7 months

First QC Date

May 19, 2021

Last Update Submit

February 28, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in HbA1C levels

    Change in HbA1C levels after energy-restricted dietary intervention with wheat bread enriched with hydroxytyrosol compared to conventional wheat bread

    12 weeks

  • Change in blood cholesterol levels

    Change in blood cholesterol levels after energy-restricted dietary intervention with wheat bread enriched with hydroxytyrosol compared to conventional wheat bread

    12 weeks

Secondary Outcomes (1)

  • Change in body weight

    12 weeks

Study Arms (2)

Wheat bread enriched with hydroxytyrosol

EXPERIMENTAL
Other: Wheat bread enriched with hydroxytyrosol

Wheat bread

ACTIVE COMPARATOR
Other: Wheat bread

Interventions

Wheat bread enriched with hydroxytyrosol

Wheat bread enriched with hydroxytyrosol

Wheat bread

Wheat bread

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • type 2 diabetes mellitus
  • bmi : 25-40 kg/ m-2
  • normal exercise and dietary habits
  • weight stable for at least 3 months before enrollment

You may not qualify if:

  • HbA1C \> 8.5%
  • pregnancy
  • chronic medical illness
  • regular intense exercise
  • alcohol consumption (\> 2 drinks/day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Laiko General Hospital, School of Medicine, National and Kapodistrian University of Athens

Athens, Attica, 11527, Greece

Location

Laiko General Hospital of Athens

Athens, Greece

Location

Related Publications (1)

  • Binou P, Stergiou A, Kosta O, Tentolouris N, Karathanos VT. Positive contribution of hydroxytyrosol-enriched wheat bread to HbA1c levels, lipid profile, markers of inflammation and body weight in subjects with overweight/obesity and type 2 diabetes mellitus. Eur J Nutr. 2023 Aug;62(5):2165-2176. doi: 10.1007/s00394-023-03133-9. Epub 2023 Apr 5.

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity

Interventions

3,4-dihydroxyphenylethanol

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Food Engineering and Physical Chemistry

Study Record Dates

First Submitted

May 19, 2021

First Posted

May 24, 2021

Study Start

May 24, 2021

Primary Completion

December 24, 2021

Study Completion

January 14, 2022

Last Updated

March 2, 2022

Record last verified: 2022-02

Data Sharing

IPD Sharing
Will not share

Locations